We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-14.49%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$400B
AUM Growth
-$75.9B
Cap. Flow
+$5.41B
Cap. Flow %
1.35%
Top 10 Hldgs %
18.01%
Holding
6,980
New
409
Increased
2,565
Reduced
2,533
Closed
543

Sector Composition

Rank Sector Weight
1 Technology 15.59%
2 Healthcare 9.3%
3 Financials 8.52%
4 Consumer Discretionary 7.65%
5 Industrials 4.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRT
5651
DELISTED
Startek Inc.
SRT
$131K ﹤0.01%
45,205
-11,760
-21% -$43.6K
APYX icon
5652
Apyx Medical
APYX
$179M
$130K ﹤0.01%
22,241
+5,580
+33% +$28.6K
BBCP icon
5653
Concrete Pumping Holdings
BBCP
$495M
$130K ﹤0.01%
21,513
-13,625
-39% -$77.3K
ORMP icon
5654
Oramed Pharmaceuticals
ORMP
$174M
$130K ﹤0.01%
28,363
-41,820
-60% -$223K
CLOE
5655
DELISTED
Clover Leaf Capital Corp. Class A Common Stock
CLOE
$130K ﹤0.01%
12,801
NOGN
5656
DELISTED
Nogin, Inc. Common Stock
NOGN
$130K ﹤0.01%
650
MBII
5657
DELISTED
Marrone Bio Innovations, Inc.
MBII
$130K ﹤0.01%
111,861
+19,269
+21% +$20.1K
STTK icon
5658
Shattuck Labs
STTK
$678M
$129K ﹤0.01%
31,731
-68,624
-68% -$248K
JOAN
5659
DELISTED
JOANN, Inc. Common Stock
JOAN
$129K ﹤0.01%
16,595
+3,014
+22% +$27.6K
PEGR
5660
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
$128K ﹤0.01%
13,168
IEAWW
5661
DELISTED
Infrastructure and Energy Alternatives, Inc. Warrant
IEAWW
$128K ﹤0.01%
125,142
ATER icon
5662
Aterian
ATER
$4.62M
$127K ﹤0.01%
4,925
-12,902
-72% -$570K
LCTX icon
5663
Lineage Cell Therapeutics
LCTX
$277M
$127K ﹤0.01%
80,169
-47,263
-37% -$62.3K
RKLY
5664
DELISTED
Rockley Photonics Holdings Limited
RKLY
$127K ﹤0.01%
58,141
-81,897
-58% -$251K
FSTX
5665
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$126K ﹤0.01%
20,146
-13,656
-40% -$46K
BFX
5666
DELISTED
BowFlex Inc.
BFX
$125K ﹤0.01%
71,325
-23,767
-25% -$65.7K
THRN
5667
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$125K ﹤0.01%
+25,944
New +$158K
BBIG
5668
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$125K ﹤0.01%
4,512
-55,451
-92% -$1.86M
CLBT icon
5669
Cellebrite
CLBT
$3.74B
$124K ﹤0.01%
24,331
+563
+2% +$2.93K
HFFG icon
5670
HF Foods Group
HFFG
$79.7M
$124K ﹤0.01%
23,824
-5,236
-18% -$29.3K
PRQR icon
5671
ProQR Therapeutics
PRQR
$241M
$124K ﹤0.01%
159,796
-616,139
-79% -$459K
ASPS icon
5672
Altisource Portfolio Solutions
ASPS
$65.3M
$123K ﹤0.01%
1,435
-963
-40% -$84K
TIGR
5673
UP Fintech Holding
TIGR
$870M
$123K ﹤0.01%
26,025
-71,015
-73% -$302K
CTSO icon
5674
Cytosorbents Corp
CTSO
$23.3M
$122K ﹤0.01%
55,714
-243,163
-81% -$558K
ALGS icon
5675
Aligos Therapeutics
ALGS
$28.2M
$120K ﹤0.01%
3,958
-1,288
-25% -$43.8K

Similar funds

Goldman Sachs's Q2 2022 Portfolio in Review

As of Q2 2022, Goldman Sachs held 6,980 positions worth $400B, down 16% from $476B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Goldman Sachs's Q2 2022 filing shows 409 new, 2,565 increased, 2,533 reduced and 543 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M. The largest sale was Invesco QQQ Trust, an estimated $993M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • Goldman Sachs's largest Q2 2022 buy was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M.
  • Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $2.97B increase.
  • Goldman Sachs's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $993M.
  • Goldman Sachs fully exited Cerner Corp in Q2 2022, selling an estimated $863M.
  • Goldman Sachs's ten largest holdings make up 18% of its $400B portfolio in Q2 2022.
  • Goldman Sachs opened 409 new positions and closed 543 in Q2 2022.
  • Goldman Sachs's portfolio value fell 16% quarter-over-quarter to $400B.

Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.